» Articles » PMID: 12684748

Reversible Nucleoside Analogue-associated Lactic Acidosis Despite a Prolonged Course

Overview
Specialty Critical Care
Date 2003 Apr 10
PMID 12684748
Authors
Affiliations
Soon will be listed here.
References
1.
Claessens Y, Cariou A, Chiche J, Dauriat G, Dhainaut J . L-Carnitine as a treatment of life-threatening lactic acidosis induced by nucleoside analogues. AIDS. 2000; 14(4):472-3. DOI: 10.1097/00002030-200003100-00029. View

2.
Fouty B, Frerman F, Reves R . Riboflavin to treat nucleoside analogue-induced lactic acidosis. Lancet. 1998; 352(9124):291-2. DOI: 10.1016/S0140-6736(05)60266-8. View

3.
Brinkman K . Editorial response: hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors. Clin Infect Dis. 2000; 31(1):167-9. DOI: 10.1086/313921. View

4.
Brinkman K, ter Hofstede H, Burger D, Smeitink J, Koopmans P . Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS. 1998; 12(14):1735-44. DOI: 10.1097/00002030-199814000-00004. View

5.
Falco V, Rodriguez D, Ribera E, Martinez E, Miro J, Domingo P . Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature. Clin Infect Dis. 2002; 34(6):838-46. DOI: 10.1086/339041. View